Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Activating brown fat may help manage PCOS symptoms.

Some people have a genetic variation that makes them less effective at breaking down drugs.

19.5% of young college girls have PCOS, highlighting the need for early screening and intervention.

A multidisciplinary approach with virtual sessions effectively reduces compulsive hair pulling in young people.

Ayurvedic treatment can effectively manage PCOD symptoms.

Longer finasteride treatment improves male pattern hair loss, with significant results at 12 months.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

PCOS affects about 6.3% of teens globally, and ongoing checks are advised for those with irregular cycles or high androgen levels.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

PRP shows potential for treating female hair loss, but more research needed.

Some women with PCOS have rare genetic variants linked to the condition.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

Certain genetic variants may increase the risk of developing PCOS.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.